{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:51:32Z","timestamp":1790365892273,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s40262-019-00846-1","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T22:02:28Z","timestamp":1575928948000},"page":"403-408","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Clinical Pharmacokinetics and Impact of Hematocrit on Monitoring and Dosing of Tacrolimus Early After Heart and Lung Transplantation"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-5771","authenticated-orcid":false,"given":"Maaike A.","family":"Sikma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine C.","family":"Hunault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alwin D. R.","family":"Huitema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan W.","family":"De Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik M.","family":"Van Maarseveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"846_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5301\/ijao.5000638","volume":"41","author":"HK Atalan","year":"2017","unstructured":"Atalan HK, Gucyetmez B, Aslan S, Yazar S, Polat KY. Postoperative acute kidney injury in living donor liver transplantation recipients. Int J Artif Organs. 2017;41:37\u201342.","journal-title":"Int J Artif Organs"},{"key":"846_CR2","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1097\/01.tp.0000542710.91578.09","volume":"102","author":"M Rayar","year":"2018","unstructured":"Rayar M, Tron C, J\u00e9z\u00e9quel C, Beaurepaire J-M, Petitcollin A, Houssel-Debry P, et al. High intrapatient variability of tacrolimus exposure in the early period after liver transplantation is associated with poorer outcomes. Transplantation. 2018;102:e108\u201314.","journal-title":"Transplantation"},{"key":"846_CR3","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1097\/TP.0000000000001243","volume":"100","author":"BJ Nankivell","year":"2016","unstructured":"Nankivell BJ, Png CH, Oconnell PJ, Chapman JR. Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: comparison of cyclosporine and tacrolimus eras. Transplantation. 2016;100:1723\u201331.","journal-title":"Transplantation"},{"key":"846_CR4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/j.1600-6143.2006.01300.x","volume":"6","author":"M Grimm","year":"2006","unstructured":"Grimm M, Rinaldi M, Yonan NA, Arpesella G, Ariz\u00f3n Del Prado JM, Pulp\u00f3n LA, et al. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients\u2014a large European trial. Am J Transplant. 2006;6:1387\u201397.","journal-title":"Am J Transplant"},{"key":"846_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2215\/CJN.04800512","volume":"8","author":"E Wehbe","year":"2013","unstructured":"Wehbe E, Duncan AE, Dar G, Budev M, Stephany B. Recovery from AKI and short- and long-term outcomes after lung transplatation. Clin J Am Soc Nephrol. 2013;8:19\u201325.","journal-title":"Clin J Am Soc Nephrol"},{"key":"846_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.transproceed.2015.12.006","volume":"48","author":"R Tjahjono","year":"2016","unstructured":"Tjahjono R, Connellan M, Granger E. Predictors of acute kidney injury in cardiac transplantation. Transpl Proc. 2016;48:167\u201372.","journal-title":"Transpl Proc"},{"key":"846_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00228-017-2204-8","volume":"73","author":"MA Sikma","year":"2017","unstructured":"Sikma MA, Hunault CC, van de Graaf EA, Verhaar MC, Kesecioglu J, de Lange DW, et al. High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury. Eur J Clin Pharmacol. 2017;73:573\u201380.","journal-title":"Eur J Clin Pharmacol"},{"key":"846_CR8","first-page":"311","volume":"43","author":"MA Sikma","year":"2018","unstructured":"Sikma MA, Hunault CC, Kirkels JH, Verhaar MC, Kesecioglu J, de Lange DW. Association of whole blood tacrolimus concentrations with kidney injury in heart transplantation patients. Eur J Drug Metabol Pharmacokinet. 2018;43:311\u201320.","journal-title":"Eur J Drug Metabol Pharmacokinet."},{"key":"846_CR9","doi-asserted-by":"crossref","unstructured":"Paradela de la Morena M, La Torre Bravos De M, Prado RF, Delgado Roel M, Garc\u00eda Salcedo JA, Fieira Costa E, et al. Chronic Kidney Disease After Lung Transplantation: Incidence, Risk Factors, and Treatment. Transplant Proc. 2010;42:3217\u20139.","DOI":"10.1016\/j.transproceed.2010.05.064"},{"key":"846_CR10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMoa021744","volume":"349","author":"AO Ojo","year":"2003","unstructured":"Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349:931\u201340.","journal-title":"N Engl J Med"},{"key":"846_CR11","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.transproceed.2007.06.073","volume":"39","author":"S Mastrobuoni","year":"2007","unstructured":"Mastrobuoni S, Ubilla M, Cordero A, Herreros J, Rabago G. Two-dose daclizumab, tacrolimus, mycophenolate mofetil, and steroid-free regimen in de novo cardiac transplant recipients: early experience. Transpl Proc. 2007;39:2163\u20136.","journal-title":"Transpl Proc"},{"key":"846_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1629","author":"TA Miano","year":"2019","unstructured":"Miano TA, Flesch JD, Feng R, Forker CM, Brown M, Oyster M, et al. Early tacrolimus concentrations after lung transplant are predicted by combined clinical and genetic factors and associated with acute kidney injury. Clin Pharmacol Ther. 2019. https:\/\/doi.org\/10.1002\/cpt.1629.","journal-title":"Clin Pharmacol Ther."},{"key":"846_CR13","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1111\/ajt.15016","volume":"18","author":"I Gueta","year":"2018","unstructured":"Gueta I, Markovits N, Yarden-Bilavsky H, Raichlin E, Freimark D, Lavee J, et al. High tacrolimus trough level variability is associated with rejections after heart transplant. Am J Transplant. 2018;18:2571\u20138.","journal-title":"Am J Transplant"},{"key":"846_CR14","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.healun.2015.05.028","volume":"34","author":"HM Gallagher","year":"2015","unstructured":"Gallagher HM, Sarwar G, Tse T, Sladden TM, Hii E, Yerkovich ST, et al. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival. J Heart Lung Transplant. 2015;34:1442\u20138.","journal-title":"J Heart Lung Transplant"},{"key":"846_CR15","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1111\/ajt.13309","volume":"15","author":"MA Sikma","year":"2015","unstructured":"Sikma MA, van Maarseveen EM, van de Graaf EA, Kirkels JH, Verhaar MC, Donker DW, et al. Pharmacokinetics and toxicity of tacrolimus early after heart and lung transplantation. Am J Transplant. 2015;15:2301\u201313.","journal-title":"Am J Transplant"},{"key":"846_CR16","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1517\/17425247.2015.1106687","volume":"12","author":"MA Sikma","year":"2015","unstructured":"Sikma MA, van Maarseveen EM, Donker DW, Meulenbelt J. Letter to the editor: \u201cImmunosuppressive drug therapy\u2014biopharmaceutical challenges and remedies\u201d. Expert Opin Drug Deliv. 2015;12:1955\u20137.","journal-title":"Expert Opin Drug Deliv"},{"key":"846_CR17","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/TP.0b013e3181a23cb2","volume":"87","author":"H Ekberg","year":"2009","unstructured":"Ekberg H, Mamelok RD, Pearson TC, Vincenti F, Tedesco-Silva H, Daloze P. The challenge of achieving target drug concentrations in clinical trials: experience from the symphony study. Transplantation. 2009;87:1360\u20136.","journal-title":"Transplantation"},{"key":"846_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/bcp.12361","volume":"78","author":"E St\u00f8rset","year":"2014","unstructured":"St\u00f8rset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, et al. Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling. Br J Clin Pharmacol. 2014;78:509\u201323.","journal-title":"Br J Clin Pharmacol"},{"key":"846_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1034\/j.1399-3046.2001.005002075.x","volume":"5","author":"N Mittal","year":"2001","unstructured":"Mittal N, Thompson JF, Kato T, Tzakis AG. Tacrolimus and diarrhea: pathogenesis of altered metabolism. Pediatr Transplant. 2001;5:75\u20139.","journal-title":"Pediatr Transplant"},{"key":"846_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1517\/17425255.1.4.641","volume":"1","author":"U Christians","year":"2005","unstructured":"Christians U, Schmitz V, Haschke M. Functional interactions between P-glycoprotein and CYP3A in drug metabolism. Expert Opin Drug Metab Toxicol. 2005;1:641\u201354.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"846_CR21","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1016\/j.transproceed.2012.09.062","volume":"44","author":"B D\u00edaz-Molina","year":"2012","unstructured":"D\u00edaz-Molina B, Tavira B, Lambert JL, Bernardo MJ, Alvarez V, Coto E. Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation. Transpl Proc. 2012;44:2635\u20138.","journal-title":"Transpl Proc"},{"key":"846_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1517\/17425255.1.4.629","volume":"1","author":"KW Renton","year":"2005","unstructured":"Renton KW. Regulation of drug metabolism and disposition during inflammation and infection. Expert Opin Drug Metab Toxicol. 2005;1:629\u201340.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"846_CR23","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1345\/aph.1K628","volume":"42","author":"S Lam","year":"2008","unstructured":"Lam S, Partovi N, Ting LSL, Ensom MHH. Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction? Ann Pharmacother. 2008;42:1037\u201347.","journal-title":"Ann Pharmacother"},{"key":"846_CR24","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2165\/00003088-200241110-00003","volume":"41","author":"U Christians","year":"2002","unstructured":"Christians U, Jacobsen W, Benet LZ, Lampen A. Mechanisms of clinically relevant drug interactions associated with tacrolimus. Clin Pharmacokinet. 2002;41:813\u201351.","journal-title":"Clin Pharmacokinet"},{"key":"846_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00007691-200410000-00008","volume":"26","author":"H Zahir","year":"2004","unstructured":"Zahir H, McCaughan G, Gleeson M, Nand RA, McLachlan AJ. Changes in tacrolimus distribution in blood and plasma protein binding following liver transplantation. Ther Drug Monit. 2004;26:506\u201315.","journal-title":"Ther Drug Monit"},{"key":"846_CR26","first-page":"290","volume":"24","author":"CS Heith","year":"2019","unstructured":"Heith CS, Hansen LA, Bakken RM, Ritter SL, Long BR, Hume JR, et al. Effects of an ex vivo pediatric extracorporeal membrane oxygenation circuit on the sequestration of mycophenolate mofetil, tacrolimus, hydromorphone, and fentanyl. J Pediatr Pharmacol Ther. 2019;24:290\u20135.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"846_CR27","unstructured":"Sikma MA, Hunault CC, van Maarseveen EM, Huitema ADR, van de Graaf EA, Kirkels JH, et al. Extreme variability of oral tacrolimus pharmacokinetics early after thoracic organ transplantation due to excessive fluctuations in bioavailability (NTR 3912). 15th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology; 24\u201327 September 2017: Kyoto."},{"key":"846_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-019-00591-7","author":"MA Sikma","year":"2019","unstructured":"Sikma MA, Hunault CC, Van Maarseveen EM, Huitema ADR, Van de Graaf EA, Kirkels JH, et al. High variability of whole-blood tacrolimus pharmacokinetics early after thoracic organ transplantation. Eur J Drug Metab Pharmacokinet (2019). https:\/\/doi.org\/10.1007\/s13318-019-00591-7.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"846_CR29","unstructured":"Sikma MA, Hunault CC, Huitema ADR, Verhaar MC, van de Graaf EA, Kirkels JH, et al. Tacrolimus whole blood and unbound plasma concentrations early after heart and lung transplantation (NTR3912). 16th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology. 16\u201319 September 2018: Brisbane."},{"key":"846_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00228-013-1584-7","volume":"70","author":"E St\u00f8rset","year":"2014","unstructured":"St\u00f8rset E, Holford N, Midtvedt K, Bremer S, Bergan S, \u00c5sberg A. Importance of hematocrit for a tacrolimus target concentration strategy. Eur J Clin Pharmacol. 2014;70:65\u201377.","journal-title":"Eur J Clin Pharmacol"},{"key":"846_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.12659\/AOT.883993","volume":"18","author":"GI Snell","year":"2013","unstructured":"Snell GI, Ivulich S, Mitchell L, Westall GP, Levvey BJ. Evolution to twice daily bolus intravenous tacrolimus: optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant. Ann Transplant. 2013;18:399\u2013407.","journal-title":"Ann Transplant."},{"key":"846_CR32","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/toxins3101332","volume":"3","author":"S Worbs","year":"2011","unstructured":"Worbs S, K\u00f6hler K, Pauly D, Avondet M-A, Schaer M, Dorner MB, et al. Ricinus communis intoxications in human and veterinary medicine-a summary of real cases. Toxins (Basel). 2011;3:1332\u201372.","journal-title":"Toxins (Basel)"},{"key":"846_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1432-2277.2011.01365.x","volume":"25","author":"A Capron","year":"2011","unstructured":"Capron A, Lerut J, Latinne D, Rahier J, Haufroid V, Wallemacq P. Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study. Transpl Int. 2011;25:41\u20137.","journal-title":"Transpl Int"},{"key":"846_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.clinbiochem.2014.12.018","volume":"48","author":"F Lemaitre","year":"2015","unstructured":"Lemaitre F, Blanchet B, Latournerie M, Antignac M, Houssel-Debry P, Verdier M-C, et al. Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells. Clin Biochem. 2015;48:406\u201311.","journal-title":"Clin Biochem"},{"key":"846_CR35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jpba.2015.01.054","volume":"107","author":"D Pensi","year":"2015","unstructured":"Pensi D, De Nicol\u00f2 A, Pinon M, Calvo PL, Nonnato A, Brunati A, et al. An UPLC-MS\/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells. J Pharm Biomed Anal. 2015;107:512\u20137.","journal-title":"J Pharm Biomed Anal"},{"key":"846_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/fcp.12412","volume":"33","author":"C Tron","year":"2019","unstructured":"Tron C, Allard M, Petitcollin A, Ferrand-Sorre M-J, Verdier M-C, Querzerho-Raguideau J, et al. Tacrolimus diffusion across the peripheral mononuclear blood cell membrane: impact of drug transporters. Fundam Clin Pharmacol. 2019;33:113\u201321.","journal-title":"Fundam Clin Pharmacol"},{"key":"846_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","volume":"41","author":"M Brunet","year":"2019","unstructured":"Brunet M, Van Gelder T, \u00c5sberg A, Haufroid V, Hesselink DA, Langman L, et al. Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit. 2019;41:261\u2013307.","journal-title":"Ther Drug Monit"},{"key":"846_CR38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1046\/j.1365-2125.2003.02008.x","volume":"57","author":"H Zahir","year":"2004","unstructured":"Zahir H, McCaughan G, Gleeson M, Nand RA, McLachlan AJ. Factors affecting variability in distribution of tacrolimus in liver transplant recipients. Br J Clin Pharmacol. 2004;57:298\u2013309.","journal-title":"Br J Clin Pharmacol"},{"key":"846_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0009-9120(96)00001-X","volume":"29","author":"N Rifai","year":"1996","unstructured":"Rifai N, Chao F-F, Pham Q, Thiessen J, Soldin SJ. The role of lipoproteins in the transport and uptake of cyclosporine and dihydro-tacrolimus into HepG2 and JURKAT cell lines. Clin Biochem. 1996;29:149\u201355.","journal-title":"Clin Biochem"},{"key":"846_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/iub.478","volume":"63","author":"S Biagiotti","year":"2011","unstructured":"Biagiotti S, Paoletti MF, Fraternale A, Rossi L, Magnani M. Drug delivery by red blood cells. IUBMB Life. 2011;63:621\u201331.","journal-title":"IUBMB Life"},{"key":"846_CR41","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jconrel.2011.05.024","volume":"154","author":"S Biagiotti","year":"2011","unstructured":"Biagiotti S, Rossi L, Bianchi M, Giacomini E, Pierig\u00e8 F, Serafini G, et al. Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs. J Control Release. 2011;154:306\u201313.","journal-title":"J Control Release"},{"key":"846_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.2042-7158.1994.tb03752.x","volume":"46","author":"K Nagase","year":"1994","unstructured":"Nagase K, Iwasaki K, Nozaki K, Noda K. Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes. J Pharm Pharmacol. 1994;46:113\u20137.","journal-title":"J Pharm Pharmacol"},{"key":"846_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1083\/jcb.141.1.143","volume":"141","author":"LD Walensky","year":"1998","unstructured":"Walensky LD, Gascard P, Fields ME, Blackshaw S, Conboy JG, Mohandas N, et al. The 13-kD FK506 binding protein, FKBP13, interacts with a novel homologue of the erythrocyte membrane cytoskeletal protein 4.1. J Cell Biol. 1998;141:143\u201353.","journal-title":"J Cell Biol"},{"key":"846_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1056-8719(02)00158-2","volume":"46","author":"H Zahir","year":"2001","unstructured":"Zahir H, Nand RA, Brown KF, Tattam BN. Validation of methods to study the distribution and protein binding of tacrolimus in human blood. J Pharmacol Toxicol Methods. 2001;46:27\u201335.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"846_CR45","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/FTD.0b013e3182708edf","volume":"34","author":"S Zheng","year":"2012","unstructured":"Zheng S, Davis CL, Hebert MF. Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit. 2012;34:660\u201370.","journal-title":"Ther Drug Monit"},{"key":"846_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.chroma.2018.03.010","volume":"1547","author":"H Bittersohl","year":"2018","unstructured":"Bittersohl H, Schniedewind B, Christians U, Luppa PB. A simple and highly sensitive on-line column extraction liquid chromatography-tandem mass spectrometry method for the determination of protein-unbound tacrolimus in human plasma samples. J Chromatogr A. 2018;1547:45\u201352.","journal-title":"J Chromatogr A"},{"key":"846_CR47","doi-asserted-by":"crossref","unstructured":"Schijvens AM, van Hesteren FHS, Cornelissen EAM, Bootsma-Robroeks CMHHT, Br\u00fcggemann RJM, Burger DM, et al. The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patients. Pediatr Nephrol. 2018;34:507\u2013515.","DOI":"10.1007\/s00467-018-4117-x"},{"key":"846_CR48","first-page":"2732","volume":"23","author":"WJ Jusko","year":"1991","unstructured":"Jusko WJ, D\u2019Ambrosio R. Monitoring FK 506 concentrations in plasma and whole blood. Transplant Proc. 1991;23:2732\u20135.","journal-title":"Transplant Proc"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-019-00846-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-019-00846-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-019-00846-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T21:14:30Z","timestamp":1607462070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-019-00846-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1007\/s40262-019-00846-1","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,10]]},"assertion":[{"value":"10 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Maaike A. Sikma, Claudine C. Hunault, Alwin D.R. Huitema, Dylan W. de Lange, and Erik M. van Maarseveen declare no conflicts of interest or financial support.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No funding was received for this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}